Vaccine Stockpile For HHS May Be Delayed By SEC Regs
This article was originally published in The Pink Sheet Daily
Executive Summary
Accounting regulations hinder booking payments from HHS for products which firms stockpile themselves, Aventis VP Hosbach says. Industry may seek an SEC exemption or a change in the contract language from CDC.
You may also be interested in...
Stockpiled Vaccine Can Be Recognized As Revenue In Next Fiscal Year, Says SEC
The "unique" nature of vaccines sold for stockpiling allows companies to record revenue without meeting traditional requirements, according to an SEC guidance.
Stockpiled Vaccine Can Be Recognized As Revenue In Next Fiscal Year, Says SEC
The "unique" nature of vaccines sold for stockpiling allows companies to record revenue without meeting traditional requirements, according to an SEC guidance.
SEC Seeks Vaccine Manufacturer Input On Pediatric Stockpile Accounting
Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.